{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:06:13Z","timestamp":1791752773205,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2929,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.exphem.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T22:47:23Z","timestamp":1391381243000},"page":"457-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesis"],"prefix":"10.1016","volume":"42","author":[{"given":"Roni","family":"Shouval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran I.","family":"Shlush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Yehudai-Resheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Pery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maty","family":"Tzukerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsila","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.01.010_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1532\/IJH97.05066","article-title":"Clinical significance of FLT3 in leukemia","volume":"82","author":"Kiyoi","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2014.01.010_bib2","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1158\/1078-0432.CCR-08-1123","article-title":"Structural and functional alterations of FLT3 in acute myeloid leukemia","volume":"15","author":"Meshinchi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2014.01.010_bib3","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature11016","article-title":"Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia","volume":"485","author":"Smith","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.01.010_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1471-2407-10-513","article-title":"FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia","volume":"10","author":"Chang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2014.01.010_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.1999.01284.x","article-title":"Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children","volume":"105","author":"Xu","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.01.010_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2011-10-388629","article-title":"Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability","volume":"120","author":"Shlush","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib8","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2002-02-0420","article-title":"Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors","volume":"100","author":"Kottaridis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib9","first-page":"275760","article-title":"The impact of FLT3 mutations on the development of acute myeloid leukemias","volume":"2013","author":"Testa","year":"2013","journal-title":"Leuk Res Treatment"},{"key":"10.1016\/j.exphem.2014.01.010_bib10","first-page":"189","article-title":"FLT3 mutations in acute myeloid leukemia","volume":"125","author":"Kiyoi","year":"2006","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.exphem.2014.01.010_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cell.2010.04.033","article-title":"Cellular heterogeneity: do differences make a difference?","volume":"141","author":"Altschuler","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.01.010_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.01.010_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.01.010_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.01.010_bib15","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","article-title":"Clinical implications of FLT3 mutations in pediatric AML","volume":"108","author":"Meshinchi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib16","first-page":"190","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.01.010_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/337181a0","article-title":"Antibodies to CD3\/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures","volume":"337","author":"Smith","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.01.010_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni1080","article-title":"Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity","volume":"5","author":"Hope","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2014.01.010_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/asheducation-2009.1.3","article-title":"Darwin and evolutionary tales in leukemia. The Ham-Wasserman Lecture","author":"Greaves","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2014.01.010_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.01.010_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2012-04-427039","article-title":"Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia","volume":"121","author":"Parkin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib22","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2012-06-431122","article-title":"Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy","volume":"121","author":"Pratcorona","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/pme.09.52","article-title":"Next-generation sequencing of cancer genomes: back to the future","volume":"6","author":"Walter","year":"2009","journal-title":"Per Med"},{"key":"10.1016\/j.exphem.2014.01.010_bib24","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.96.8.4494","article-title":"Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells","volume":"96","author":"Klein","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2014.01.010_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature07485","article-title":"DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome","volume":"456","author":"Ley","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.01.010_bib26","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1182\/blood-2011-06-363960","article-title":"Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation","volume":"119","author":"Man","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.leu.2404246","article-title":"Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples","volume":"20","author":"Cloos","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.01.010_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2008-01-132431","article-title":"Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia","volume":"112","author":"Raghavan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmed.2009.01.005","article-title":"Uniparental disomy in cancer","volume":"15","author":"Tuna","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.exphem.2014.01.010_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/gcc.20573","article-title":"Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia","volume":"47","author":"Gupta","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2014.01.010_bib31","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood-2010-06-289207","article-title":"Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation","volume":"118","author":"Kharazi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib32","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2007-08-109942","article-title":"Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model","volume":"111","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.01.010_bib33","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/leu.2012.115","article-title":"Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia","volume":"26","author":"Stone","year":"2012","journal-title":"Leukemia"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:31:47Z","timestamp":1759566707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0301472X14000575"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.01.010","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesis","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}